Rubicon Research Private Limited 2024-09-25 Health moderate FDA
Health · FDA · Recall #FDA-D-0659-2024
AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen… Recall
Issued September 25, 2024 · Rubicon Research Private Limited
In September 2024, Rubicon Research Private Limited recalled the AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen…, a moderate health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Discoloration
What you should do
- 1 Stop using AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Rubicon Research Private Limited to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Rubicon Research Private Limited
- Category
- Health
- Recall date
- September 25, 2024
- Units affected
- Not reported
- Sold at
- Nationwide in the US
- Recall number
- FDA-D-0659-2024
- Made in
- India
- Issuing agency
- FDA
In context
- Rubicon Research Private Limited has 2 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.